SPARC and melanoma: An increase in cell size was associated with a delay in the G1/S phase [38, 39]; interestingly, SPARC-deficient melanoma cells exhibited a delay in S phase entry suggesting a clear link between the downregulation of SPARC levels, increase in cells’ size and cycling arrest [3, 40–42].